Tag: Clinicalinvestigation

Sleeping pill reduces levels of Alzheimer’s proteins (Links to an external site)

Photo of KL2 alum, Dr. Brendan Lucey.

KL2 alum, Brendan Lucey, MD is the senior author of a recent small, proof-of-concept study published in the Annals of Neurology (April 20). Lucey and a team of researchers at Washington University School of Medicine found that two doses of an FDA-approved sleeping pill reduced levels of Alzheimer’s proteins. The study hints at the potential […]